Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Jun;12(2):223-32.
doi: 10.1208/s12248-010-9181-5. Epub 2010 Mar 3.

Pancreatic cancer: pathobiology, treatment options, and drug delivery

Jing Li  1 , M Guillaume Wientjes, Jessie L-S Au
Affiliations
Review

Pancreatic cancer: pathobiology, treatment options, and drug delivery

Jing Li et al. AAPS J. 2010 Jun.

Abstract

Pancreatic cancer is the fourth leading cause of cancer-related deaths in the USA. The high mortality rate is partly due to lack of effective treatments. This review summarizes the pathobiology and current treatment options for pancreatic cancer. Moreover, the review discusses the opportunities of developing novel therapies for pancreatic cancer provided by the progress in understanding the genetic mutations, tumor microenvironment, cancer stem cells, and drug delivery.

PubMed Disclaimer

References

    1. American Cancer Society. Estimated new cancer cases and deaths by sex, US. http://www.cancer.org. Accessed 20 Dec 2009.
    1. Michaud DS. Epidemiology of pancreatic cancer. Minerva Chir. 2004;59:99–111. - PubMed
    1. Borja-Cacho D, Jensen EH, Saluja AK, Buchsbaum DJ, Vickers SM. Molecular targeted therapies for pancreatic cancer. Am J Surg. 2008;196:430–41. - PMC - PubMed
    1. Gutt R, Liauw SL, Weichselbaum RR. Adjuvant radiotherapy for resected pancreatic cancer: a lack of benefit or a lack of adequate trials? Nat Clin Pract Gastroenterol Hepatol. 2009;6:38–46. - PubMed
    1. Mahalingam D, Kelly KR, Swords RT, Carew J, Nawrocki ST, Giles FJ. Emerging drugs in the treatment of pancreatic cancer. Expert Opin Emerg Drugs. 2009;14:311–28. - PubMed

Publication types

MeSH terms

Substances